Deerfield
About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More
---
Investment

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More
---
Information

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---
Philanthropy

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
---
Portfolio Companies

Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.

Read More View Portfolio Companies
---
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More View Research Collaborations
---
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Read More
---
Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
---
Cure Campus

Cure is a 12-story innovation campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Events at the Cure

Deerfield Management and the Deerfield Foundation Announce the Creation of the American Society of Hematology (ASH) Peter Steelman Scholar Award and the First Annual AML Summit to Advance Research for Acute Myeloid Leukemia

NEW YORK, NEW YORK – June 8, 2023Deerfield Management and the Deerfield Foundation announced today the creation of the American Society of Hematology (ASH) Peter Steelman Scholar Award and the first Annual AML Summit in honor of former, longtime Deerfield Partner Peter Steelman. Both efforts aim to further advance research for Acute Myeloid Leukemia (AML).

The 2022 inaugural recipient of the ASH Peter Steelman Scholar Award is Simone Riedel, Ph.D. who will be a keynote speaker at the AML Summit. Dr. Riedel currently serves as a doctoral fellow at The Children’s Hospital of Philadelphia’s Bernt Lab, as part of a team of researchers focused on investigating the role of epigenetic gene regulation in hematopoietic stem cells and their relation to leukemia. More specifically, Dr. Riedel works on a protein called Meningioma-1 (MN1) that, when overexpressed, causes a highly aggressive AML.

The first annual AML Summit will be held on Tuesday, June 13 at Cure®, a healthcare innovation campus in New York City.

Guest speakers at the inaugural AML Summit will include:

  • Omar Abdel-Wahab, M.D., Director of the Center for Hematologic Malignancies at Memorial Sloan Kettering;
  • Lore Gruenbaum, Ph.D. | Vice President, Therapy Acceleration Program;
  • Ross Levine, M.D., Leukemia Specialist & Physician-Scientist, at Memorial Sloan Kettering Cancer Center, Chair of The AML Summit;
  • Alicia Loffler, former Executive Director of the Innovation and New Ventures Office at Northwest